tradingkey.logo
搜索

Bionano Genomics Inc

BNGO
添加自选
1.150USD
-0.040-3.36%
收盘 05/15, 16:00美东报价延迟15分钟
13.20M总市值
亏损市盈率 TTM

Bionano Genomics Inc

1.150
-0.040-3.36%
查看详细走势图
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-3.36%

5天

-10.85%

1月

-8.73%

6月

-24.34%

今年开始到现在

-24.84%

1年

-69.66%

TradingKey Bionano Genomics Inc股票评分

单位: USD 更新时间: 2026-05-15

操作建议

Bionano Genomics Inc当前公司基本面数据相对稳定,最新ESG披露属于行业领先水平。增长潜力较大。当前估值合理,在医疗设备与耗材行业排名139/206位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价5.00。中期看,股价处于平稳状态。近一个月,市场表现较差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。

Bionano Genomics Inc评分

相关信息

行业排名
139 / 206
全市场排名
361 / 4482
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Bionano Genomics Inc亮点

亮点风险
Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
业绩增长期
公司处于发展阶段,最新年度总收入28.51M美元
估值低估
公司最新PE估值-0.24,处于3年历史低位
机构加仓
最新机构持股1.17M股,环比增加2.69%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值0.00

分析师目标

根据 2 位分析师
买入
评级
5.000
目标均价
+320.17%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Bionano Genomics Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Bionano Genomics Inc简介

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
公司代码BNGO
公司Bionano Genomics Inc
CEOHolmlin (R. Erik)
网址https://bionano.com/
KeyAI